Phase I BLASST-3 Trial

Clinical trial NCT04972253 · WITHDRAWN

Trial details

NCT number: NCT04972253
Sponsor: Guru P. Sonpavde
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Bladder Transitional Cell Carcinoma Bladder Cancer Fibroblast Growth Factor Receptor

Start date: 2021-12-23
Primary completion: 2022-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.